All authors read and approved Berzosertib molecular weight the final manuscript.”
“Background Methylsulfonylmethane (MSM) is a naturally occurring nutrient composed of sulfur, oxygen and methyl groups [1]. In the presence of ozone and high-energy ultraviolet light, MSM (along with dimethyl sulfoxide [DMSO]) is formed from dimethyl sulfide, taken up into atmosphere, returned to the earth in rainfall, and taken into the root systems of plants. As such, MSM can be found in small quantities in a variety of foods [2], such as milk, fruits and vegetables (e.g., tomatoes, corn), coffee, and tea. While multiple health-related benefits are attributed to sulfur in general [3], and to MSM specifically—ranging from improved physical

function [4] to a potential reduction in certain cancer risk [5], the proposed mechanisms of action for MSM appear related to both anti-inflammatory [6]

and anti-oxidative activity [7]. MSM may inhibit the translocation of the p65 subunit of nuclear factor (NF)-kß to the nucleus [6], thus minimizing downstream events associated with local and systemic inflammation. Indeed, supplementation with MSM may GS-4997 datasheet minimize the expression of pro-inflammatory cytokines [8]. MSM has been reported to increase antioxidant defense (glutathione) [9], as well as decrease the actual production of reactive oxygen species (ROS) [7]. As with pro-inflammatory biomarkers, supplementation with MSM has resulted in a lowering of multiple oxidative stress bioNocodazole in vivo markers [10, 11]. Collectively, these findings suggest that MSM might favorably influence exercise recovery, as both inflammation and oxidative stress may be involved in the etiology of exercise-induced muscle damage and associated symptoms [12]. Considering this and the excellent safety profile of MSM, we used a pilot (proof of concept) study design to determine the influence

of MSM on markers of exercise recovery and performance in healthy men. At the time of study conception, we were unaware of any published trials focused on the use of Cyclin-dependent kinase 3 MSM as a potential exercise recovery agent. We hypothesized that MSM would favorably influence our outcome measures (e.g., reduce muscle soreness, reduce muscle fatigue, increase antioxidant capacity), providing justification for further study of this ingredient using a larger scale, placebo controlled study design. Methods Subjects and screening Eight healthy men (27.1 ± 6.9 yrs old) who were considered to be moderately exercise-trained (exercising <150 minutes per week) were recruited to participate in an open label (unblinded) pilot study. Eligibility was determined by completion of a health history form (Physical Activity Readiness Questionnaire [PAR-Q]) and physical examination. All subjects had experience performing resistance exercise, to ensure that the exercise protocol they were exposed to in the present design did not present a novel challenge.